Topics

AIM ImmunoTech Inc: AIM ImmunoTech, Inc. Announces Pricing of $8 Million Public Offering

09:56 EDT 25 Sep 2019 | FinanzNachrichten

OCALA, FL / ACCESSWIRE / September 25, 2019 / AIM ImmunoTech, Inc. (NYSE American:AIM) (the "Company"), an immuno-pharma company focused on the research and development of therapeutics to treat mul...

Original Article: AIM ImmunoTech Inc: AIM ImmunoTech, Inc. Announces Pricing of $8 Million Public Offering

NEXT ARTICLE

More From BioPortfolio on "AIM ImmunoTech Inc: AIM ImmunoTech, Inc. Announces Pricing of $8 Million Public Offering"

Quick Search